Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.40 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.40 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.40 |
| ▸ | GLRB | P48167 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.40 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6851698 | 0.83 | CA2 (0.43) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| SCHEMBL6851693 | 0.83 | CA2 (0.43) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4896805 | 0.81 | SMN1; SMN2 (0.61) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL35141 | 0.77 | CA2 (0.67) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4894218 | 0.75 | CA2 (0.52) | CA2CA1SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL29226791 | 0.74 | CA2 (0.47) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8986512 | 0.73 | CA2 (0.61) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| SCHEMBL29226894 | 0.73 | HSP90AA1 (0.47) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29226877 | 0.73 | CA2 (0.45) | CA2CA1HSP90AA1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4884903 | 0.73 | CYP1A2 (0.38) | CA2CA1SMN1; SMN2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255240-A1 | Sulfonamide Derivatives | NOVO NORDISK A/S (DK) | 2008-10-16 | — | — | US | disclosed |
| EP-1756025-A1 | SULFONAMIDE DERIVATIVES | NOVO NORDISK A/S (DK) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005105712-A1 | SULFONAMIDE DERIVATIVES | NOVO NORDISK A/S (DK) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255240-A1 | Sulfonamide Derivatives | FABP4, SQOR, CS | CA2 1064/4885CA1 3874/4885HSP90AA1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.